Literature DB >> 16088244

Long-term outcome of patients with large overcorrection following surgery for exotropia.

Tae Woo Kim1, Jeong Hun Kim, Jeong-Min Hwang.   

Abstract

To provide long-term surgical results for patients with large initial overcorrection following surgery for exodeviation, 68 consecutive patients with initial overcorrection of 20 prism diopters (PD) or more at distance or near following surgery for exodeviation performed between 1994 and 2002 were included in this study. The patients were managed with an alternate full-time occlusion, echothiophate iodide, or prism glasses for the period of overcorrection. One day postoperatively, the amount of overcorrection was 8--40 PD at distance and 0--35 PD at near, and decreased to 10 PD or less both at distance and near vision within 4 weeks postoperatively in 49 patients (72%). Seven patients needed prism glasses for esotropia of less than 10 PD. Four patients (5.9%) needed a reoperation for consecutive esotropia and 1 patient for postoperative hypotropia following recession of the superior and lateral rectus. The final outcome showed orthophoria to exo/esodeviation of <or=10 PD in 48 patients (71%) and exodeviations of >10 PD in 11 patients (16%) at near or distance. In conclusion, overcorrection was reduced to 10 PD or less at distance and near within 4 weeks after surgery in most patients. Even with initial overcorrection of 20 PD or more after surgery for exodeviation, reoperation for consecutive esotropia was necessary only in 5.9% of the patients. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16088244     DOI: 10.1159/000085734

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  13 in total

1.  Reply to 'Results of conservative management for consecutive esotropia after intermittent exotropia surgery'.

Authors:  D W Kim; S Y Han; U S Kim; S-H Baek
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

2.  Unilateral lateral rectus advancement with medial rectus recession vs bilateral medial rectus recession for consecutive esotropia.

Authors:  Shin Hae Park; Hyun Kyung Kim; Youn Hea Jung; Sun Young Shin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

3.  Results of conservative management for consecutive esotropia after intermittent exotropia surgery.

Authors:  D W Kim; S Han; U S Kim; S-H Baek
Journal:  Eye (Lond)       Date:  2015-03-27       Impact factor: 3.775

4.  Surgical outcomes of symmetric and asymmetric surgery for intermittent exotropia with postoperative large early overcorrection.

Authors:  Hwan Heo; Mi Sun Sung; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2013-07-06       Impact factor: 2.447

5.  Postoperative outcomes of patients initially overcorrected for intermittent exotropia.

Authors:  Stacy L Pineles; Luke W Deitz; Federico G Velez
Journal:  J AAPOS       Date:  2011-12       Impact factor: 1.220

6.  Survival analysis following early surgical success in intermittent exotropia surgery.

Authors:  Joo Yeon Lee; Sung Ju Ko; Sung Uk Baek
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

7.  Autonomic drugs and the accommodative system in rhesus monkeys.

Authors:  Lisa A Ostrin; Adrian Glasser
Journal:  Exp Eye Res       Date:  2009-09-24       Impact factor: 3.467

8.  Factors affecting surgical outcome of intermittent exotropia.

Authors:  Chee-Ming Lee; Ming-Hui Sun; Ling-Yuh Kao; Ken-Kuo Lin; Meng-Ling Yang
Journal:  Taiwan J Ophthalmol       Date:  2018 Jan-Mar

9.  High Accommodative Convergence/Accommodation Ratio Consecutive Esotropia Following Surgery for Intermittent Exotropia: Clinical Feature, Diagnosis, and Treatment.

Authors:  Byung Joo Lee; Hyun Taek Lim
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241

10.  Surgical outcomes of unilateral recession and resection in intermittent exotropia according to forced duction test results.

Authors:  Seonghwan Kim; Hee Kyung Yang; Jeong-Min Hwang
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.